With the loss of 140 jobs by the end of 2015
Pfizer is to shut down its manufacturing plant in West Ryde, Sydney, Australia, cutting 140 jobs.
The firm said it would phase out operations at the plant, which makes tablets and capsules, by the end of 2015.
'Pfizer has been reviewing its global manufacturing network and capacity in response to changing global demand as a result of the patent expiry of a number of key medicines, and the need to achieve greater efficiencies in our manufacturing operations,' said Manufacturing Director and Site Leader Justin Mathie.
'In addition, our industry is seeing a trend away from high-volume medicines, to high value but lower volume medicines that target a specific patient population or disease condition. This requires more flexible manufacturing facilities and a different overall approach to manufacturing.'
Pfizer’s Perth manufacturing facility, the larger of Pfizer’s two manufacturing sites in Australia, will continue to manufacture complex aseptic products (sterile injectables), for the domestic and export markets.